Gregory W. Roloff, MD

Articles by Gregory W. Roloff, MD

$Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.$

Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL

ByGregory W. Roloff, MD

June 25th 2023

Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.

Latest Updated Articles

$Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.$
Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL
Published: June 25th 2023 | Updated:

Gregory W. Roloff, MD

Articles by Gregory W. Roloff, MD

Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC

FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer

Monitoring Response to Radioligand Therapy in Prostate Cancer

KEYNOTE-B61 Trial Review

Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases